CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Biofinity XRdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02060539
NCT02060539N/ACompleted
CompareCT.gov

Multicenter Dispensing Study of Biofinity Lenses in Extended Range

CooperVision, Inc.·interventional·Posted Feb 12, 2014·Updated Dec 11, 2017

In Brief

A clinical study evaluating Biofinity XR for Myopia and Hyperopia. Completed, enrolled 19 participants across 4 sites in 2 countries.

Detailed Summary

To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Hyperopia
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 12, 2014
Enrollment StartOct 1, 2013
Primary CompletionApr 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 12.4 years ago

Interventions

Biofinity XRdevice